Protheragen-ING

Protheragen-ING logo

Protheragen-ING is engaged in the introduction of various chemical products to the global market, including active pharmaceutical ingredients (APIs), pharmaceutical excipients, veterinary chemicals, membrane materials, packaging materials. We are also a solution provider for chemistry-related analysis services.

Company Website

Product Listing

Rimegepant inquiry  | Purity Not Available

Protheragen-ING

Rimegepant is a small molecule inhibitor of the calcitonin gene-related peptide (CGRP) receptor that blocks the action of CGRP, a potent vasodilator believed to play a role in migraine headaches. Rimegepant is approved for treatment of acute migraine attacks. In clinical trials, rimegepant was generally well tolerated with only rare instances of transient serum aminotransferase […]

More Information Supplier Page

Riociguat inquiry  | Purity Not Available

Protheragen-ING

It is used for treatment of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension It has a role as a soluble guanylate cyclase activator and an antihypertensive agent.

More Information Supplier Page

Risdiplam inquiry  | Purity Not Available

Protheragen-ING

Risdiplam is an orally bioavailable mRNA splicing modifier used for the treatment of spinal muscular atrophy (SMA). It increases systemic SMN protein concentrations by improving the efficiency of SMN2 gene transcription.

More Information Supplier Page

Ritalinic acid inquiry  | Purity Not Available

Protheragen-ING

Ritalinic acid is a monocarboxylic acid that is phenylacetic acid substituted by a piperidin-2-yl group at position 2. It is a metabolite of the drug methylphenidate. It has a role as a marine xenobiotic metabolite and a drug metabolite. It is a monocarboxylic acid and a member of piperidines.

More Information Supplier Page

Rivaroxaban inquiry  | Purity Not Available

Protheragen-ING

Rivaroxaban is an anticoagulant and the first orally active direct factor Xa inhibitor. Unlike warfarin, routine lab monitoring of INR is not necessary.

More Information Supplier Page

Rivaroxaban Intermediates II inquiry  | Purity Not Available

Protheragen-ING

An impurity of Rivaroxaban.Metabolite.Rivaroxaban inhibits both free Factor Xa and Factor Xa bound in the prothrombinase complex. It is a highly selective direct Factor Xa inhibitor with oral bioavailability and rapid onset of action

More Information Supplier Page

Rivaroxaban Intermediates III inquiry  | Purity Not Available

Protheragen-ING

An impurity of Rivaroxaban. Rivaroxaban inhibits both free Factor Xa and Factor Xa bound in the prothrombinase complex. It is a highly selective direct Factor Xa inhibitor with oral bioavailability and rapid onset of action.

More Information Supplier Page

Rocuronium Bromide inquiry  | Purity Not Available

Protheragen-ING

Rocuronium Bromide is the bromide salt form of rocuronium, an intermediate-acting quaternary aminosteroid with muscle relaxant property. Rocuronium bromide competitively binds to the nicotinic receptor at the motor end plate, and antagonizes acetylcholine binding, which results in skeletal muscle relaxation and paralysis.

More Information Supplier Page

Rosmarinic acid inquiry  | Purity Not Available

Protheragen-ING

(R)-rosmarinic acid is a stereoisomer of rosmarinic acid having (R)-configuration. It has a role as a plant metabolite and a geroprotector. It is a conjugate acid of a (R)-rosmarinate. It is an enantiomer of a (S)-rosmarinic acid.

More Information Supplier Page

Rotigotine inquiry  | Purity Not Available

Protheragen-ING

Rotigotine (Neupro) is a non-ergoline dopamine agonist indicated for the treatment of Parkinson’s disease (PD) and restless legs syndrome (RLS) in Europe and the United States. It is formulated as a once-daily transdermal patch which provides a slow and constant supply of the drug over the course of 24 hours. Like other dopamine agonists, rotigotine […]

More Information Supplier Page

Rotundine inquiry  | Purity Not Available

Protheragen-ING

It has a role as an adrenergic agent, a non-narcotic analgesic and a dopaminergic antagonist.

More Information Supplier Page

rU Phosphoramidite inquiry  | Purity Not Available

Protheragen-ING

5′-DMT-2’O-TBDMS-rU Phosphoramidite is a classic 2-OTBDMS phosphoramidite used to incorporate U into synthetic oligonucleotides.

More Information Supplier Page

Rupatadine Fumarate inquiry  | Purity Not Available

Protheragen-ING

Rupatadine inhibits both platelet-activating factor (PAF) and histamine (H1) effects through its interaction with specific receptors.

More Information Supplier Page

Ruphos Pd G3 inquiry  | Purity Not Available

Protheragen-ING

Ruphos Pd G3 is an organic noble metal catalyst, which is mainly used as a catalyst in coupling reactions such as Suzuki, Kumada, and Negishi.

More Information Supplier Page

Rutin inquiry  | Purity Not Available

Protheragen-ING

Rutin is a rutinoside that is quercetin with the hydroxy group at position C-3 substituted with glucose and rhamnose sugar groups. It has a role as a metabolite and an antioxidant. It is a disaccharide derivative, a quercetin O-glucoside, a tetrahydroxyflavone and a rutinoside.

More Information Supplier Page

Rutin inquiry  | Purity Not Available

Protheragen-ING

Rutin is a flavonoid found in rue leaves, buckwheat, and other plants. Rutin helps prevent a couperose condition and demonstrates anti-oxidant properties.

More Information Supplier Page

Ruxolitinib inquiry  | Purity Not Available

Protheragen-ING

Used as the phosphate salt for the treatment of patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis. It has a role as an antineoplastic agent and an EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor.

More Information Supplier Page

Ruxolitinib Phosphate inquiry  | Purity Not Available

Protheragen-ING

Used for the treatment of patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis. It has a role as an antineoplastic agent and an EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor.

More Information Supplier Page

S-Phos inquiry  | 0.99%

Protheragen-ING

S-Phos is a catalyst that is used in the preparation of thiadiazoles as DGAT1 inhibitors with potential in metabolic diseases treatment.

More Information Supplier Page

Saccharin Sodium inquiry  | Purity Not Available

Protheragen-ING

Sweeteners, widely used in food and drugs, are generally applied as pharmaceutical excipients to flavor oral liquids, orally disintegrating tablets, oral tablets and other dosage forms.

More Information Supplier Page

Sacubitril sodium inquiry  | Purity Not Available

Protheragen-ING

Sacubitril sodium is a potent and orally active NEP (neprilysin) inhibitor, with an IC50 of 5 nM. Sacubitril sodium enhances the tone of the natriuretic peptide (NP) system and exerts significant antihypertensive effects. Sacubitril sodium is a component of the heart failure medicine LCZ696. Sacubitril sodium can be used for the research of heart failure, […]

More Information Supplier Page

Sacubitril Valsartan Sodium inquiry  | Purity Not Available

Protheragen-ING

Sacubitril valsartan sodium is an angiotensin receptor-neprilysin inhibitor (ARNi) for the treatment of high blood pressure and heart failure.

More Information Supplier Page

Safinamide Mesylate inquiry  | Purity Not Available

Protheragen-ING

Safinamide is a highly selective MAO-B inhibitor in rat brain mitochondria, with an IC50 of 98 nM. safinamide inhibits MAO-B in human brain with an IC50 of 9 nM.

More Information Supplier Page